Dr Ruth Frampton
Selected publications
See all publications- 2024Diabetic Medicine : A Journal of the British Diabetic Association10.1111/dme.15377
Reducing cardiometabolic risk with semaglutide in type 1 diabetes (RESET1): Study protocol of a phase 2 double-blinded randomised placebo-controlled trial.